Insights into Molecular cancer therapy: NOS-2 suppresses the expression of tumor suppressor TIMP3 via up regulation of its target gene, 16/February/2014, 7.18 am

Therapeutic insights into the targeting of cancer cell proliferation, migration, and invasion: ATRA (a derivative of Vitamin-A) suppresses the expression of PIK3CA via up regulation of its target gene, 16/February/2014, 7.13 am
February 16, 2014
Insights into Anti-metastatic therapy: 1,25-dihydroxyvitamin D suppresses the expression of PIK3CD via up regulation of its target gene,16/February/2014, 7.27 am
February 16, 2014
Show all

Noble Laureate in Medicine (1998) Prof. Dr Ferid M (The University of Texas, Houston, Texas, USA) has suggested in a number of papers that inhibition of NOS2 (Nitric oxide synthase) may have a therapeutic value in a number of cancers.  

In connection with this finding, Dr L Boominathan, Director-cum-chief scientist of GBMD, reports that: Molecular insights into Cancer therapy: NOS-2 suppresses the expression of tumor suppressor TIMP3 via up regulation of its target gene. This study provides mechanistic insights into how inhibition of NOS-2 may improve caner therapy.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Insights into Molecular cancer therapy: NOS-2 suppresses the expression of tumor suppressor TIMP3 via up regulation of its target gene, 16/February/2014, 7.18 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.